Related Experiment Video
Updated: Jun 13, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
[Echinocandins and the 2009 guidelines for treatment of candidiasis]
1Faculdade de Medicina da Universidade de Joinville, and Setor de Doenças Infecciosas do Hospital Regional Hans Dieter Schmidt, Joinville, Santa Catarina, Brazil.
Abstract:
Candida is the most frequent cause of invasive fungal infections in humans that yield high levels of mortality and health-related costs. Several factors lead to the development of candidemia. The Infectious Diseases Society of America (IDSA) updated its guidelines for the management of candidiasis and proper use of antifungal agents in Candida infections. The echinocandins are novel antifungal 1,3-beta-glucan synthase inhibitors and are currently the first choice treatment for most Candida infections, with good responses to support its use.
Related Concept Videos
Antifungal Agents
Cryptococcal Meningitis
Candidiasis
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Anthelminthic Agents
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
